Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults

Exclusion Criteria

• •Symptoms of spreading of the disease to the brain that requires treatment with drugs called steroids.
• •Any active infection.
• •Severe medical problems other than the diagnosis of SCLC, that would limit the ability of the patient to follow study guidelines or that would expose the patient to extreme risk.
• •Ongoing or planned chemotherapy, immunotherapy, radiotherapy, or investigational therapy for the treatment of SCLC.
• •Use of an investigational drug within 30 days before the first dose of study medication.
• •Women who are pregnant or lactating.
• •Patients of child-bearing potential who refuse to practice an adequate form of birth control.
• •Patients with clinical evidence of any stomach or intestinal (GI) condition.
• •Patients requiring treatment with the drug cyclosporin A.